GKOS (STOCKS)
Glaukos Corporation
$118.660000
+2.260000 (+1.94%)
Prev close: $116.400000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas William Burns
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,891.63M
- Employees
- 995
- P/E (TTM)
- -35.59
- P/B (TTM)
- 10.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.28 | $-0.20 | -0.0799 | -39.93% |
|
Sep 2025 (Q3)
|
$-0.16 | $-0.26 | +0.1029 | +39.14% |
|
Jun 2025 (Q2)
|
$-0.24 | $-0.27 | +0.0299 | +11.08% |
|
Mar 2025 (Q1)
|
$-0.22 | $-0.35 | +0.1346 | +37.96% |
Financial Statements
| Revenues | $507.44M |
| Benefits Costs and Expenses | $700.48M |
| Cost Of Revenue | $111.81M |
| Costs And Expenses | $700.48M |
| Gross Profit | $282.76M |
| Nonoperating Income/Loss | $6.56M |
| Operating Expenses | $482.36M |
| Selling, General, and Administrative Expenses | $331.75M |
| Other Operating Expenses | $150.61M |
| Operating Income/Loss | -$199.60M |
| Income/Loss From Continuing Operations After Tax | -$187.69M |
| Income/Loss From Continuing Operations Before Tax | -$193.04M |
| Income Tax Expense/Benefit | -$5.35M |
| Income Tax Expense/Benefit, Current | $1.14M |
| Income Tax Expense/Benefit, Deferred | -$6.49M |
| Net Income/Loss | -$187.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$187.69M |
| Net Income/Loss Available To Common Stockholders, Basic | -$187.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.28 |
| Diluted Earnings Per Share | -$3.28 |
| Basic Average Shares | 57,190,000 |
| Diluted Average Shares | 57,190,000 |
| Assets | $893.49M |
| Current Assets | $474.98M |
| Inventory | $63.56M |
| Other Current Assets | $411.42M |
| Noncurrent Assets | $418.50M |
| Fixed Assets | $113.25M |
| Intangible Assets | $141.92M |
| Other Non-current Assets | $163.33M |
| Liabilities | $237.33M |
| Current Liabilities | $101.28M |
| Accounts Payable | $24.62M |
| Other Current Liabilities | $76.65M |
| Noncurrent Liabilities | $136.06M |
| Equity | $656.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $656.16M |
| Liabilities And Equity | $893.49M |
| Net Cash Flow From Operating Activities | -$14.79M |
| Net Cash Flow From Operating Activities, Continuing | -$14.79M |
| Net Cash Flow From Investing Activities | -$77.61M |
| Net Cash Flow From Investing Activities, Continuing | -$77.61M |
| Net Cash Flow From Financing Activities | $11.89M |
| Net Cash Flow From Financing Activities, Continuing | $11.89M |
| Net Cash Flow | -$80.52M |
| Net Cash Flow, Continuing | -$80.52M |
| Comprehensive Income/Loss | -$187.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$187.00M |
| Other Comprehensive Income/Loss | $688.00K |